aTyr Pharma (LIFE) Misses Q2 EPS by 6c

aTyr Pharma (NASDAQ: LIFE) reported Q2 EPS of ($0.44), $0.06 worse than the analyst estimate of ($0.38).

For earnings history and earnings-related data on aTyr Pharma (LIFE) click here.

You May Also Be Interested In

• Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
• ArcelorMittal (MT:NA) (MT) PT Raised to EUR65 at Jefferies
• Morgan Stanley turns cautious on freight stocks despite stronger cycle outlook